Create a narrative

Harmony Biosciences Holdings Community

NasdaqGM:HRMY Community

2 Narratives written by author
0 Comments on narratives written by author
95 Fair Values set on narratives written by author

Create a narrative

Harmony Biosciences Holdings

AN

AnalystConsensusTarget

Consensus Narrative from 9 Analysts

Pitolisant HD And ZYN002 Developments Will Expand Future Revenue Opportunities

Key Takeaways Strategic acquisitions and CNS pipeline advancements aim to boost revenue streams and capitalize on high-value sales opportunities. Extensions in regulatory exclusivity for pitolisant and Pitolisant HD developments could enhance margins and market presence.

US$51.22

FV

34.7% undervalued

18.32%

Revenue growth p.a.

1

0

65

7 days ago